-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Fresh Tracks Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Fresh Tracks Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$1.65M, a 64% increase year-over-year.
- Fresh Tracks Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$6.36M, a 70.5% increase year-over-year.
- Fresh Tracks Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$6.36M, a 70.5% increase from 2022.
- Fresh Tracks Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$21.5M, a 46.5% increase from 2021.
- Fresh Tracks Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$40.2M, a 91.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)